ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
Holding IPA?
Track your performance easily

ImmunoPrecise Antibodies (IPA) Financial Statements

143 Followers

ImmunoPrecise Antibodies Financial Overview

ImmunoPrecise Antibodies's market cap is currently ―. The company's EPS TTM is $-0.762; its P/E ratio is -0.58; ImmunoPrecise Antibodies is scheduled to report earnings on December 12, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total RevenueC$ 5.26MC$ 6.46MC$ 6.22MC$ 6.15MC$ 5.69M
Gross ProfitC$ 2.36MC$ 3.11MC$ 3.20MC$ 2.95MC$ 2.79M
EBITC$ -4.63MC$ -18.83MC$ -3.46MC$ -2.59MC$ -3.83M
EBITDAC$ -3.23MC$ -17.25MC$ -2.15MC$ -1.24MC$ -2.33M
Net Income Common StockholdersC$ -4.00MC$ -18.05MC$ -2.94MC$ -2.62MC$ -3.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 3.91MC$ 3.46MC$ 6.20MC$ 6.02MC$ 6.73M
Total AssetsC$ 59.30MC$ 59.94MC$ 78.69MC$ 75.61MC$ 76.58M
Total DebtC$ 13.50MC$ 13.68MC$ 14.39MC$ 9.57MC$ 9.81M
Net DebtC$ 9.59MC$ 10.22MC$ 8.19MC$ 3.56MC$ 3.09M
Total LiabilitiesC$ 26.45MC$ 26.07MC$ 28.87MC$ 23.58MC$ 22.74M
Stockholders EquityC$ 32.85MC$ 33.92MC$ 49.82MC$ 52.03MC$ 53.84M
Cash Flow-
Free Cash FlowC$ -2.09MC$ -3.77MC$ -501.00KC$ -534.00KC$ -689.00K
Operating Cash FlowC$ -1.82MC$ -2.64MC$ -666.00KC$ -235.00KC$ -553.00K
Investing Cash FlowC$ -263.00KC$ -1.11MC$ 57.00KC$ -312.00KC$ -197.00K
Financing Cash FlowC$ 2.70MC$ 1.12MC$ 613.00KC$ -310.00KC$ -405.00K
Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

ImmunoPrecise Antibodies Debt to Assets

ImmunoPrecise Antibodies Cash Flow

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis